Neurogene Inc. Cash Equivalents, at Carrying Value
Neurogene Inc. (NGNE) had Cash Equivalents, at Carrying Value of $118.20 million as of 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2020-05-06
- 2020-03-31: Cash Equivalents, at Carrying Value $118.20M.
- 2019-12-31: Cash Equivalents, at Carrying Value $40.00M.
- 2019-09-30: Cash Equivalents, at Carrying Value $44.04M.
- 2019-06-30: Cash Equivalents, at Carrying Value $49.67M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2020-03-31 | $118.20M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $40.00M 10-Q · filed 2020-05-06 | |
| 2019-09-30 | $44.04M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $49.67M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $50.20M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $51.87M 10-Q · filed 2019-11-13 | |
| 2018-09-30 | $51.58M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $49.89M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $27.30M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $39.45M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $23.57M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $17.73M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $2.23M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $28.57M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $73.22M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $14.57M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $31.62M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $37.39M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $16.39M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $11.28M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $8.03M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $6.55M 10-K · filed 2016-03-14 | $6.56M 10-K · filed 2015-03-16 |
| 2014-09-30 | $11.58M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $15.75M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $3.38M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $3.71M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |